GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (LTS:0RD1) » Definitions » Gross Profit

Camurus AB (LTS:0RD1) Gross Profit : kr1,738 Mil (TTM As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Camurus AB Gross Profit?

Camurus AB's gross profit for the three months ended in Dec. 2024 was kr520 Mil. Camurus AB's gross profit for the trailing twelve months (TTM) ended in Dec. 2024 was kr1,738 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Camurus AB's gross profit for the three months ended in Dec. 2024 was kr520 Mil. Camurus AB's Revenue for the three months ended in Dec. 2024 was kr553 Mil. Therefore, Camurus AB's Gross Margin % for the quarter that ended in Dec. 2024 was 93.98%.

Camurus AB had a gross margin of 93.98% for the quarter that ended in Dec. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Camurus AB was 99.85%. The lowest was 77.95%. And the median was 91.19%.


Camurus AB Gross Profit Historical Data

The historical data trend for Camurus AB's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camurus AB Gross Profit Chart

Camurus AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 300.71 515.22 853.08 1,594.50 1,738.07

Camurus AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 342.00 359.12 413.06 446.08 519.81

Competitive Comparison of Camurus AB's Gross Profit

For the Biotechnology subindustry, Camurus AB's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Camurus AB's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Camurus AB's Gross Profit distribution charts can be found below:

* The bar in red indicates where Camurus AB's Gross Profit falls into.


;
;

Camurus AB Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Camurus AB's Gross Profit for the fiscal year that ended in Dec. 2024 is calculated as

Gross Profit (A: Dec. 2024 )=Revenue - Cost of Goods Sold
=1867.581 - 129.507
=1,738

Camurus AB's Gross Profit for the quarter that ended in Dec. 2024 is calculated as

Gross Profit (Q: Dec. 2024 )=Revenue - Cost of Goods Sold
=553.131 - 33.321
=520

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1,738 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Camurus AB's Gross Margin % for the quarter that ended in Dec. 2024 is calculated as

Gross Margin % (Q: Dec. 2024 )=Gross Profit (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=520 / 553.131
=93.98 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Camurus AB  (LTS:0RD1) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Camurus AB had a gross margin of 93.98% for the quarter that ended in Dec. 2024 => Durable competitive advantage


Camurus AB Gross Profit Related Terms

Thank you for viewing the detailed overview of Camurus AB's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Camurus AB Business Description

Traded in Other Exchanges
Address
Ideon Science Park, Lund, SWE, SE-223 70
Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The Camurus' clinical pipeline includes products for the treatment of dependence, pain, cancer and endocrine diseases, which are developed in-house and in collaboration with international pharmaceutical companies. The company's product pipeline includes CAM2029, CAM4072 and CAM2043.

Camurus AB Headlines

No Headlines